Nortech Systems (NSYS)
Market Price (12/4/2025): $6.91 | Market Cap: $19.2 MilSector: Health Care | Industry: Life Sciences Tools & Services
Nortech Systems (NSYS)
Market Price (12/4/2025): $6.91Market Cap: $19.2 MilSector: Health CareIndustry: Life Sciences Tools & Services
Investment Highlights
Why It Matters
Which of these 2 stories sounds closer for this stock?
1. Generates cash flow
The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.
2. Riding a trend
Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow
| Low stock price volatilityVol 12M is 50% | Weak multi-year price returns2Y Excs Rtn is -75%, 3Y Excs Rtn is -128% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -1.8 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -1.5% |
| Megatrend and thematic driversMegatrends include Automation & Robotics, Digital Health & Telemedicine, and Sustainable Infrastructure. Themes include Factory Automation, Show more. | Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 82% | |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -14%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -1.7%, Rev Chg QQuarterly Revenue Change % is -9.5% | ||
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -3.0%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -3.6% | ||
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -17% |
| Low stock price volatilityVol 12M is 50% |
| Megatrend and thematic driversMegatrends include Automation & Robotics, Digital Health & Telemedicine, and Sustainable Infrastructure. Themes include Factory Automation, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -75%, 3Y Excs Rtn is -128% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -1.8 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -1.5% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 82% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -14%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -1.7%, Rev Chg QQuarterly Revenue Change % is -9.5% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -3.0%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -3.6% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -17% |
Valuation, Metrics & Events
NSYS Stock
Why The Stock Moved
Qualitative Assessment
AI Generated Analysis | Feedback
Nortech Systems (NSYS) stock experienced a significant decline around the end of the third quarter of 2025 and early fourth quarter, with one report indicating a 21.15% drop following its Q3 2025 earnings announcement and another highlighting a 29.09% fall over the last month. This downturn can be attributed to several key factors:
1. Net Sales Decrease and Net Loss in Q3 2025: Nortech Systems reported a 2.9% decrease in net sales for Q3 2025 compared to the previous year, reaching $30.5 million. The company also posted a net loss of $146,000, or $(0.05) per basic share, in Q3 2025, which, despite being an improvement from a larger net loss in Q3 2024, still indicates a lack of profitability.
2. Projected Losses for Fiscal Years 2025 and 2026: The company's future guidance, announced alongside its Q3 2025 financial results, included projected losses for both fiscal years 2025 and 2026, which likely contributed to investor concerns about future profitability.
Stock Movement Drivers
Return vs. Risk
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| NSYS Return | 47% | 44% | 18% | -23% | 9% | -33% | 41% |
| Peers Return | 52% | 3% | -11% | -6% | -18% | 41% | 52% |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 16% | 112% |
Monthly Win Rates [3] | |||||||
| NSYS Win Rate | 42% | 58% | 50% | 50% | 50% | 20% | |
| Peers Win Rate | 50% | 42% | 40% | 35% | 31% | 53% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 70% | |
Max Drawdowns [4] | |||||||
| NSYS Max Drawdown | -45% | -21% | -6% | -39% | -2% | -34% | |
| Peers Max Drawdown | -31% | -15% | -31% | -31% | -27% | -13% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: A, ATEC, CERS, AVRT, BLLN.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/3/2025 (YTD)
How Low Can It Go
| Event | NSYS | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -59.2% | -25.4% |
| % Gain to Breakeven | 145.1% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -49.8% | -33.9% |
| % Gain to Breakeven | 99.0% | 51.3% |
| Time to Breakeven | 164 days | 148 days |
| 2018 Correction | ||
| % Loss | -57.4% | -19.8% |
| % Gain to Breakeven | 134.8% | 24.7% |
| Time to Breakeven | 417 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -83.4% | -56.8% |
| % Gain to Breakeven | 504.2% | 131.3% |
| Time to Breakeven | 4742 days | 1480 days |
Compare to A, ATEC, CERS, AVRT, BLLN
In The Past
Nortech Systems's stock fell -59.2% during the 2022 Inflation Shock from a high on 7/12/2022. A -59.2% loss requires a 145.1% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
Trade Ideas
Select past ideas related to NSYS. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11142025 | CRL | Charles River Laboratories International | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 4.1% | 4.1% | -3.7% |
| 11142025 | GDRX | GoodRx | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | -9.8% | -9.8% | -11.8% |
| 11142025 | ASTH | Astrana Health | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 6.0% | 6.0% | -5.5% |
| 11142025 | SGRY | Surgery Partners | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 9.7% | 9.7% | -1.4% |
| 11072025 | TFX | Teleflex | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 6.2% | 6.2% | -5.1% |
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11142025 | CRL | Charles River Laboratories International | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 4.1% | 4.1% | -3.7% |
| 11142025 | GDRX | GoodRx | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | -9.8% | -9.8% | -11.8% |
| 11142025 | ASTH | Astrana Health | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 6.0% | 6.0% | -5.5% |
| 11142025 | SGRY | Surgery Partners | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 9.7% | 9.7% | -1.4% |
| 11072025 | TFX | Teleflex | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 6.2% | 6.2% | -5.1% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Nortech Systems
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 21.23 |
| Mkt Cap | 1.8 |
| Rev LTM | 464 |
| Op Inc LTM | -6 |
| FCF LTM | -2 |
| FCF 3Y Avg | -8 |
| CFO LTM | 19 |
| CFO 3Y Avg | -5 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 8.8% |
| Rev Chg 3Y Avg | 4.6% |
| Rev Chg Q | 12.3% |
| QoQ Delta Rev Chg LTM | 2.9% |
| Op Mgn LTM | -3.2% |
| Op Mgn 3Y Avg | -5.0% |
| QoQ Delta Op Mgn LTM | 0.8% |
| CFO/Rev LTM | 3.3% |
| CFO/Rev 3Y Avg | -3.4% |
| FCF/Rev LTM | -0.2% |
| FCF/Rev 3Y Avg | -5.0% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 1.8 |
| P/S | 2.3 |
| P/EBIT | -14.5 |
| P/E | -10.9 |
| P/CFO | 42.6 |
| Total Yield | -6.1% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | -2.5% |
| D/E | 0.3 |
| Net D/E | 0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 6.6% |
| 3M Rtn | 26.5% |
| 6M Rtn | 34.3% |
| 12M Rtn | 10.2% |
| 3Y Rtn | -27.0% |
| 1M Excs Rtn | 6.6% |
| 3M Excs Rtn | 17.0% |
| 6M Excs Rtn | 19.6% |
| 12M Excs Rtn | -5.2% |
| 3Y Excs Rtn | -95.8% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 6302025 | 8072025 | 10-Q 6/30/2025 |
| 3312025 | 5142025 | 10-Q 3/31/2025 |
| 12312024 | 3312025 | 10-K 12/31/2024 |
| 9302024 | 11072024 | 10-Q 9/30/2024 |
| 6302024 | 8082024 | 10-Q 6/30/2024 |
| 3312024 | 5142024 | 10-Q 3/31/2024 |
| 12312023 | 3202024 | 10-K 12/31/2023 |
| 9302023 | 11142023 | 10-Q 9/30/2023 |
| 6302023 | 8092023 | 10-Q 6/30/2023 |
| 3312023 | 5102023 | 10-Q 3/31/2023 |
| 12312022 | 3172023 | 10-K 12/31/2022 |
| 9302022 | 11092022 | 10-Q 9/30/2022 |
| 6302022 | 8102022 | 10-Q 6/30/2022 |
| 3312022 | 5102022 | 10-Q 3/31/2022 |
| 12312021 | 3172022 | 10-K 12/31/2021 |
| 9302021 | 11102021 | 10-Q 9/30/2021 |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |